Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances — Systematic review and meta-analysis
Highlights
► Timeline Follow-Back (TLFB) validly detects use of illicit substances. ► TLFB provides an inexpensive alternative to biological samples. ► TLFB may be superior to biological samples for quantification of substance use.
Introduction
Many studies involving use, abuse, and dependence of substances such as alcohol or illicit drugs rely on self-reported measures of consumed amounts. The Timeline Follow-Back (TLFB) instrument is a commonly used self-report instrument used for assessing frequency and quantity of substance use (Sobell & Sobell, 1992). The instrument is interviewer-administered, using a visual calendar in which the respondent charts life events in order to enhance recall of substance use.
The TLFB instrument was originally developed with the intent of measuring alcohol consumption, and a number of studies have explored its validity in this context. Most studies find the instrument to be a highly valid measure of alcohol consumption (Carney et al., 1998, Grant et al., 1995, Sobell et al., 1996, Sobell et al., 1988, Toll et al., 2006), whereas a few find the validity to be modest (Searles et al., 2002, Searles et al., 2000). Using TLFB to estimate frequency and amount of tobacco smoking also produces valid results (Collins et al., 2009, Lewis-Esquerre et al., 2005, Toll et al., 2005). These findings on legal substances do not necessarily, however, extrapolate to detection of illicit substances. The validity of TLFB in measuring use of illicit substances has never been explored in a systematic review. Such validation will be useful in the context of randomized clinical trials (RCTs), cohort studies, case–control studies, etc. In particular, establishing the validity of TLFB in clinical populations such as patients with substance use disorders may be of importance both for research and treatment purposes. If TLFB is a valid description of patterns and amounts of illicit substance use, it holds practical advantages over the use of biological measures such as samples of urine, blood, or hair. For instance, it is less costly as it does not involve the use of laboratory and storage equipment, and may also be more acceptable to patients and research subjects than having to deliver a biological sample. Additionally, detection of substances in biological samples is limited to the length of time the substance or its metabolites are detectable in the sample. The TLFB is not, however, intended to enhance truthfulness of self-report, only to enhance recall.
In this article, we attempt to answer the following question through a systematic review and meta-analysis of existing literature: How well does TLFB measure consumption of cannabis and other illicit substances in comparison to biological measures such as blood, hair, or urine?
Section snippets
Methods
The protocol for this systematic review was made publically available on www.currentprotocols.com prior to initiation of the literature search (Hjorthøj, Hjorthøj, & Nordentoft, 2009).
Results
Fig. 1 details the literature retrieval process as a QUOROM flow chart (Moher et al., 1999). Of 58 retrieved papers that applied both TLFB and biological measures, we excluded four as applying positive or negative reinforcement (Feucht et al., 1994, Moore and Budney, 2002, Yacoubian, 2003, Zlotnick et al., 2009), one where agreement data was reported elsewhere (Baer et al., 2008), and 28 due to them not reporting on agreement, and authors either replying that they could provide no such data or
Discussion
The included papers were almost exclusively on subjects with a diagnosis of alcohol or illicit substance use disorder. Consequently, all conclusions relate only to this group of people, and results of this systematic review cannot necessarily be generalized to e.g. general populations. Generally, TLFB for detection of illicit substances had high levels of overall agreement with biological measures. There was some variation, however, with some studies reporting what might be considered medium
Role of funding source
Funding for this study came from funds and grants supporting the CapOpus trial, specifically supplied by: The Lundbeck Foundation, The Municipality of Copenhagen, The Egmont Foundation, The Health Insurance Foundation, The Ministry of Social Welfare, Aase and Ejnar Danielsen's Foundation, and the Wørzner Foundation. The foundations etc. providing funds and grants were not involved in any manner in design and conduct of the study; collection, management, analysis, and interpretation of the data;
Contributors
All authors wrote and approved the protocol. CRH extracted references from data sources. CRH and ARH selected papers for inclusion in the review. CRH extracted and synthesized data from individual studies. All authors actively drafted the manuscript and have approved the final manuscript.
Conflict of interest
The authors have no conflicting interests and have no financial or other relationship relevant to the subject of this article.
References (78)
- et al.
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study
Drug and Alcohol Dependence
(2006) - et al.
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence
Journal of Substance Abuse Treatment
(2007) - et al.
Acute and protracted cocaine abstinence in an outpatient population: A prospective study of mood, sleep and withdrawal symptoms
Drug and Alcohol Dependence
(2000) - et al.
Validity of the timeline followback among treatment-seeking smokers in Germany
Drug and Alcohol Dependence
(2009) - et al.
Psychometric support for contemporaneous and retrospective youth and parent reports of adolescent marijuana use frequency in an adolescent outpatient treatment population
Addictive Behaviors
(2007) - et al.
Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment
Journal of Substance Abuse Treatment
(2002) - et al.
Assessing illicit substance use in schizophrenia: The relationship between self report and detection by hair analysis
Schizophrenia Research
(2009) - et al.
Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people
Journal of Affective Disorders
(2010) - et al.
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence
Drug and Alcohol Dependence
(2006) - et al.
Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence
Addictive Behaviors
(1999)
Assessment of motivation to change substance use in dually-diagnosed schizophrenia patients
Addictive Behaviors
Validation of the timeline follow-back in the assessment of adolescent smoking
Drug and Alcohol Dependence
Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder
Drug and Alcohol Dependence
Desipramine treatment of cocaine-dependent patients with depression: A placebo-controlled trial
Drug and Alcohol Dependence
A placebo-controlled trial of buspirone for the treatment of marijuana dependence
Drug and Alcohol Dependence
Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses
Lancet
Abstinence at intake for marijuana dependence treatment predicts response
Drug and Alcohol Dependence
Application of the Transtheoretical Model of change: Psychometric properties of leading measures in patients with co-occurring drug abuse and severe mental illness
Addictive Behaviors
External pressure, motivation, and treatment outcome among pregnant substance-using women
Drug and Alcohol Dependence
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence
Journal of Substance Abuse Treatment
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence
Addictive Behaviors
Divalproex utility in bipolar disorder with co-occurring cocaine dependence: A pilot study
Addictive Behaviors
fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders
Drug and Alcohol Dependence
The reliability of the Alcohol Timeline Followback when administered by telephone and by computer
Drug and Alcohol Dependence
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day
Drug and Alcohol Dependence
Atomoxetine for treatment of marijuana dependence: A report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study
Drug and Alcohol Dependence
Correspondence between Interactive Voice Response (IVR) and Timeline Followback (TLFB) reports of drinking behavior
Addictive Behaviors
Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users
Journal of Substance Abuse Treatment
A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence
Drug and Alcohol Dependence
Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD
Behavior Therapy
Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment
The American Journal on Addictions
A controlled evaluation and description of individual-cognitive problem solving and family-behavior therapies in dually-diagnosed conduct-disordered and substance-dependent youth
Journal of Child and Adolescent Substance Abuse
Adolescent change language within a brief motivational intervention and substance use outcomes
Psychology of Addictive Behaviors
Brief motivational intervention with homeless adolescents: Evaluating effects on substance use and service utilization
Psychology of Addictive Behaviors
The Cannabis Use Problems Identification Test (CUPIT): Development, reliability, concurrent and predictive validity among adolescents and adults
Addiction
Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder
Experimental and Clinical Psychopharmacology
Levels and patterns of alcohol consumption using timeline follow-back, daily diaries and real-time “electronic interviews”
Journal of Studies on Alcohol
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial
Archives of General Psychiatry
Risk reduction for substance use and trauma-related psychopathology in adolescent sexual assault victims: Findings from an open trial
Child Maltreatment
Cited by (230)
Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorder
2023, Addictive Behaviors ReportsGroup behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial
2023, Drug and Alcohol DependenceCitation Excerpt :Further, the potential effect of targeting different treatment components such as reinforcement for abstinence compared to values-based activities with contingency management may be a promising future direction. The sustained decrease in substance-related problems at all follow-up timepoints across conditions adds to a growing literature indicating that SUD treatment can result in notable positive outcomes even among those who continue using substances or return to use after treatment (Kidorf et al., 2011; Witkiewitz et al., 2020). This underscores the importance of considering a broader range of outcomes in addition to substance use when evaluating the effectiveness of SUD treatment, including reductions in adverse health, social, legal, or economic problems related to substance use.